HMRI was founded in 1952 with the goal of developing knowledge and technology to change the way physicians diagnose and treat diseases.
HMRI is the product of multiple roots, including the Institute of Medical Research at Huntington Hospital, the Pasadena Neurovascular Foundation, the Huntington Institute of Applied Medical Research and the Pasadena Foundation for Medical Research.
Two HMRI founding medical directors, George Sharp, MD, and Hunter Shelden, MD, molded our research programs based on their research at Memorial Sloan Kettering Cancer Center and the Mayo Clinic.
Dr. Richard J. Bing (1901-2010) left an indelible mark at HMRI. His discoveries in cardiology, cardiac metabolism, cardiac catheterization, congenital heart disease, blood flow measurement in the heart, his later important work (completed in his eighties and nineties) on nitric oxide and its relation to restoring blood flow after a heart attack, and on the dangers of COX-2 inhibitors, gave him the reputation of a renaissance researcher among his colleagues.
He joined the Institutes in 1969 and left his research laboratory at the age of 98, having published the last ones of his more than 500 journal articles and medical books in his nineties.
Bing set the standard for generations of researchers to come. He is unquestionably one of the HMRI giants on whose shoulders we stand.